BlackRock Investment Management’s Regulus Therapeutics RGLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$334K Hold
1,236
﹤0.01% 3141
2016
Q3
$489K Sell
1,236
-1
-0.1% -$411 ﹤0.01% 3060
2016
Q2
$429K Buy
1,237
+405
+49% +$290K ﹤0.01% 3130
2016
Q1
$692K Buy
832
+14
+2% +$11.1K ﹤0.01% 2733
2015
Q4
$856K Buy
818
+2
+0.2% +$2K ﹤0.01% 2715
2015
Q3
$641K Sell
816
-20
-2% -$20.5K ﹤0.01% 2914
2015
Q2
$1.1M Buy
836
+465
+125% +$750K ﹤0.01% 2698
2015
Q1
$755K Buy
371
+7
+2% +$15.2K ﹤0.01% 2715
2014
Q4
$700K Buy
364
+28
+8% +$49.8K ﹤0.01% 2795
2014
Q3
$275K Buy
336
+15
+5% +$12.7K ﹤0.01% 3194
2014
Q2
$310K Buy
321
+85
+36% +$72.8K ﹤0.01% 3188
2014
Q1
$255K Buy
236
+11
+5% +$12.2K ﹤0.01% 3204
2013
Q4
$200K Sell
225
-4
-2% -$3.44K ﹤0.01% 3218
2013
Q3
$259K Buy
229
+22
+11% +$26K ﹤0.01% 3145
2013
Q2
$244K Buy
+207
New +$197K ﹤0.01% 3127

Other funds holding RGLS